Cancer Research
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Cancer Research 67, 433-436, January 15, 2007. doi: 10.1158/0008-5472.CAN-06-3114
© 2007 American Association for Cancer Research
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Singh, A. P.
Right arrow Articles by Batra, S. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Singh, A. P.
Right arrow Articles by Batra, S. K.
Related Collections
Right arrow Clinical Research
Right arrow Clinical Research: Response Markers and Mechanisms

Reviews

Emerging Roles of MUC4 in Cancer: A Novel Target for Diagnosis and Therapy

Ajay P. Singh1, Pallavi Chaturvedi1 and Surinder K. Batra1,2

1 Department of Biochemistry and Molecular Biology and 2 Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, Nebraska

Requests for reprints: Surinder K. Batra, Department of Biochemistry and Molecular Biology, Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE 68198-5870. Phone: 402-559-5455; Fax: 402-559-6650; E-mail: sbatra{at}unmc.edu.

The MUC4 mucin is a transmembrane glycoprotein that is implicated in the pathogenesis of pancreatic cancer and is aberrantly expressed in many other epithelial carcinomas. Recent studies suggest its significant potential as a clinical tool for cancer diagnosis and prognosis. MUC4 modulates HER2/ErbB2 signaling and is a determinant of therapeutic outcome of Herceptin-based therapy, which further indicates its prospective usefulness in cancer therapy and treatment planning. [Cancer Res 2007;67(2):433–6]




This article has been cited by other articles:


Home page
 J. Clin. Pathol.Home page
A S Mall
Analysis of mucins: role in laboratory diagnosis
J. Clin. Pathol., September 1, 2008; 61(9): 1018 - 1024.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
A. Vincent, M.-P. Ducourouble, and I. Van Seuningen
Epigenetic regulation of the human mucin gene MUC4 in epithelial cancer cell lines involves both DNA methylation and histone modifications mediated by DNA methyltransferases and histone deacetylases
FASEB J, August 1, 2008; 22(8): 3035 - 3045.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
P. Chaturvedi, A. P. Singh, S. Chakraborty, S. C. Chauhan, S. Bafna, J. L. Meza, P. K. Singh, M. A. Hollingsworth, P. P. Mehta, and S. K. Batra
MUC4 Mucin Interacts with and Stabilizes the HER2 Oncoprotein in Human Pancreatic Cancer Cells
Cancer Res., April 1, 2008; 68(7): 2065 - 2070.
[Abstract] [Full Text] [PDF]

Home page
 FASEB J.Home page
P. Chaturvedi, A. P. Singh, and S. K. Batra
Structure, evolution, and biology of the MUC4 mucin
FASEB J, April 1, 2008; 22(4): 966 - 981.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2007 by the American Association for Cancer Research.